Cargando…
Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study
OBJECTIVES: Hydroxychloroquine (HCQ) is widely used to treat rheumatic diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and Sjögren’s syndrome (SS). Cardiac arrhythmia has been concerned as important safety issue for HCQ. The aim of this study was to investigate wheth...
Autores principales: | Lo, Chien-Hsien, Wei, James Cheng-Chung, Wang, Yu-Hsun, Tsai, Chin-Feng, Chan, Kuei-Chuan, Li, Li-Ching, Lo, Tse-Hsien, Su, Chun-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050346/ https://www.ncbi.nlm.nih.gov/pubmed/33868251 http://dx.doi.org/10.3389/fimmu.2021.631869 |
Ejemplares similares
-
Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study
por: Lo, Chien-Hsien, et al.
Publicado: (2021) -
Trends in diagnostic approaches for pediatric appendicitis: nationwide population-based study
por: Luo, Chih-Cheng, et al.
Publicado: (2017) -
Hydroxychloroquine in rheumatic autoimmune disorders and beyond
por: Nirk, Eliise Laura, et al.
Publicado: (2020) -
Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study
por: Chen, Hsin-Hua, et al.
Publicado: (2018) -
Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders
por: Plastiras, Sotiris C, et al.
Publicado: (2021)